Document is current
Any future updates will be listed below
-
Authors
Mingels, Clemens https://orcid.org/0000-0001-6761-5323
Madani, Mohammad H.
Sen, Fatma
Nalbant, Hande
Riess, Jonathan W.
Abdelhafez, Yasser G.
Ghasemiesfe, Ahmadreza
Rominger, Axel
Guindani, Michele
Badawi, Ramsey D.
Spencer, Benjamin A.
Nardo, Lorenzo
-
Funding
Funding for this research was provided by:
University of Bern
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 20 February 2025
First Online: 21 March 2025
Declarations
:
: This study was approved by the UC Davis institutional review board (IRB 1506448). Written informed consent for inclusion was obtained. The study was performed in accordance with the Declaration of Helsinki.
: AR has received research support and speaker honoraria from Siemens and is an editor of this journal. LN is principal investigator of a service agreement with United Imaging Healthcare. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is PI of clinical trials supported by Telix Pharmaceuticals, Lantheus Medical Imaging and GE Healthcare. LN and RDB are PIs of a clinical trial supported by Lilly. RDB received research support from United Imaging Healthcare during this work. UC Davis has a revenue sharing agreement with United Imaging Healthcare. FS is PI of clinical research sponsored by Biogen. JWR has received consulting/advisory board fees from Boehringer Ingelheim, Daiichi Sankyo, Merck, EMD Serono, Roche/Genentech, BMS, Regeneron, Merus NV, Catalyst, Oncohost and Janssen and research funding to institution from AstraZeneca/MedImmune, Boehringer Ingelheim, Merck, Novartis, Revolution Medicines, Nuvalent, Summit, and Pfizer/SeaGen. All other authors have no conflicts of interest to report. RDB is PI on a study sponsored by Lilly.
